Radiological characteristics of hepatocellular carcinoma that achieved complete response after chemoembolization with drug-eluting beads for liver transplantation planning

被引:0
作者
Valle, Leonardo Guedes Moreira [1 ]
Cunha, Marcela Juliano Silva [1 ]
Schmid, Bruno Pagnin [1 ]
Falsarella, Priscila Mina [1 ]
de Rezende, Marcelo Bruno [1 ]
Felga, Guilherme Eduardo Goncalves [1 ]
Ogawa, Renata Emy [1 ]
Garcia, Rodrigo Gobbo [1 ]
Affonso, Breno Boueri [1 ]
Nasser, Felipe [1 ]
Galastri, Francisco Leonardo [1 ]
机构
[1] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil
来源
EINSTEIN-SAO PAULO | 2023年 / 21卷
关键词
Living donors; Liver neoplasms; Carcinoma; hepatocellular; Chemoembolization; therapeutic; Neoadjuvant therapy; Response evaluation criteria in solid tumors; Radiology; interventional; TRANSARTERIAL CHEMOEMBOLIZATION;
D O I
10.31744/einstein_journal/2023AO0307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe the radiological characteristics of hepatocellular carcinoma (HCC) lesions that achieved a complete response following drug-eluting bead transarterial chemoembolization (DEB-TACE) preceding liver transplantation. Methods: This single-center case-control study enrolled patients with hepatocellular carcinoma who underwent neoadjuvant DEB-TACE therapy, were followed up with contrast-enhanced magnetic resonance imaging or computed tomography, and were successively evaluated according to the modified Response Evaluation Criteria in Solid Tumors. The HCCs were divided into two groups based on their diameter (Group A: <= 3cm; Group B: 3cm). Viability was assessed using the Kaplan-Meier method according to tumor size categories. The relationship between tumor variables was analyzed using bivariate Cox regression.Results: Three-hundred and twenty-eight patients with 667 hepatocellular carcinomas who underwent their first DEB-TACE session were enrolled. A total of 105 hepatocellular carcinomas in 59 patients exhibited complete response after the initial DEB-TACE session and were divided into Group A (92 HCCs) and Group B (13 HCCs). The diameter in Group A decreased significantly compared to the pre-procedure size until the second assessment (p<0.001), with no subsequent reduction in diameter, despite maintaining a complete response. In Group B, the reduction in diameter remained significant compared with the initial value until the sixth imaging evaluation (p=0.014). The average reduction was 45.1% for Group B and a maximum of 14.9% in Group A.Conclusion: HCCs >3cm exhibited a greater reduction in size and a longer time to recurrence. HCCs <= 3cm had a shorter relapse time. The recurrence rates were similar. These findings may aid in planning for liver transplantation.
引用
收藏
页数:7
相关论文
共 15 条
  • [1] Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging
    Affonso, Breno Boueri
    Galastri, Francisco Leonardo
    da Motta Leal Filho, Joaquim Mauricio
    Nasser, Felipe
    Falsarella, Priscila Mina
    Cavalcante, Rafael Noronha
    de Almeida, Marcio Dias
    Goncalves Felga, Guilherme Eduardo
    Moreira Valle, Leonardo Guedes
    Wolosker, Nelson
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (37) : 5687 - 5701
  • [2] Current locoregional therapies and treatment strategies in hepatocellular carcinoma
    Cardarelli-Leite, L.
    Hadjivassiliou, A.
    Klass, D.
    Chung, J.
    Ho, S. G. F.
    Lim, H. J.
    Kim, P. T. W.
    Mujoomdar, A.
    Liu, D. M.
    [J]. CURRENT ONCOLOGY, 2020, 27 : S144 - S151
  • [3] Tumour evolution in hepatocellular carcinoma
    Craig, Amanda J.
    Von Felden, Johann
    Garcia-Lezana, Teresa
    Sarcognato, Samantha
    Villanueva, Augusto
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (03) : 139 - 152
  • [4] European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
  • [5] Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma
    Galastri, Francisco Leonardo
    Nasser, Felipe
    Affonso, Breno Boueri
    Moreira Valle, Leonardo Guedes
    Odisio, Bruno Calazans
    Motta-Leal Filho, Joaquim Mauricio
    Salvalaggio, Paolo Rogerio
    Garcia, Rodrigo Gobbo
    de Almeida, Marcio Dias
    Baroni, Ronaldo Hueb
    Wolosker, Nelson
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (01) : 21 - 33
  • [6] Epidemiology and Management of Hepatocellular Carcinoma
    Kulik, Laura
    El-Serag, Hashem B.
    [J]. GASTROENTEROLOGY, 2019, 156 (02) : 477 - +
  • [7] Liver Transplantation Beyond Milan Criteria
    Lingiah, Vivek A.
    Niazi, Mumtaz
    Olivo, Raquel
    Paterno, Flavio
    Guarrera, James V.
    Pyrsopoulos, Nikolaos T.
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2020, 8 (01) : 69 - 75
  • [8] Llovet JM, 2020, J HEPATOL, V72, P288, DOI 10.1016/j.jhep.2019.09.026
  • [9] Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
    Makary, Mina S.
    Khandpur, Umang
    Cloyd, Jordan M.
    Mumtaz, Khalid
    Dowell, Joshua D.
    [J]. CANCERS, 2020, 12 (07) : 1 - 18
  • [10] Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation
    Nicolini, Daniele
    Agostini, Andrea
    Montalti, Roberto
    Mocchegiani, Federico
    Mincarelli, Cinzia
    Mandolesi, Alessandra
    Robertson, Nicola L.
    Candelari, Roberto
    Giovagnoni, Andrea
    Vivarelli, Marco
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (20) : 3690 - 3701